InterCure Statistics
Total Valuation
InterCure has a market cap or net worth of $104.82 million. The enterprise value is $126.86 million.
| Market Cap | 104.82M |
| Enterprise Value | 126.86M |
Important Dates
The next estimated earnings date is Friday, August 23, 2024, after market close.
| Earnings Date | Aug 23, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
InterCure has 45.57 million shares outstanding. The number of shares has increased by 0.97% in one year.
| Shares Outstanding | 45.57M |
| Shares Change (YoY) | +0.97% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 39.76% |
| Owned by Institutions (%) | 14.68% |
| Float | 24.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 6.94 |
| PS Ratio | 1.07 |
| Forward PS | 0.35 |
| PB Ratio | 0.84 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.85 |
| Quick Ratio | 1.40 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.03 |
Financial Efficiency
Return on equity (ROE) is -13.00%.
| Return on Equity (ROE) | -13.00% |
| Return on Assets (ROA) | -7.10% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $362,772 |
| Profits Per Employee | -$63,217 |
| Employee Count | 270 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 2.16 |
Taxes
In the past 12 months, InterCure has paid $619,089 in taxes.
| Income Tax | 619,089 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +36.91% in the last 52 weeks. The beta is 0.05, so InterCure's price volatility has been lower than the market average.
| Beta (5Y) | 0.05 |
| 52-Week Price Change | +36.91% |
| 50-Day Moving Average | 2.62 |
| 200-Day Moving Average | 1.91 |
| Relative Strength Index (RSI) | 46.60 |
| Average Volume (20 Days) | 33,519 |
Short Selling Information
The latest short interest is 51,498, so 0.11% of the outstanding shares have been sold short.
| Short Interest | 51,498 |
| Short Previous Month | 60,196 |
| Short % of Shares Out | 0.11% |
| Short % of Float | 0.21% |
| Short Ratio (days to cover) | 1.18 |
Income Statement
In the last 12 months, InterCure had revenue of $97.95 million and -$17.07 million in losses. Loss per share was -$0.37.
| Revenue | 97.95M |
| Gross Profit | 28.94M |
| Operating Income | 1.53M |
| Pretax Income | -16.44M |
| Net Income | -17.07M |
| EBITDA | -11.01M |
| EBIT | -11.01M |
| Loss Per Share | -$0.37 |
Balance Sheet
The company has $30.57 million in cash and $52.61 million in debt, giving a net cash position of -$22.05 million or -$0.48 per share.
| Cash & Cash Equivalents | 30.57M |
| Total Debt | 52.61M |
| Net Cash | -22.05M |
| Net Cash Per Share | -$0.48 |
| Equity (Book Value) | 125.34M |
| Book Value Per Share | 2.75 |
| Working Capital | 53.13M |
Cash Flow
In the last 12 months, operating cash flow was -$14.77 million and capital expenditures -$714,376, giving a free cash flow of -$15.48 million.
| Operating Cash Flow | -14.77M |
| Capital Expenditures | -714,376 |
| Free Cash Flow | -15.48M |
| FCF Per Share | -$0.34 |
Margins
Gross margin is 29.55%, with operating and profit margins of 1.57% and -17.43%.
| Gross Margin | 29.55% |
| Operating Margin | 1.57% |
| Pretax Margin | -16.79% |
| Profit Margin | -17.43% |
| EBITDA Margin | -11.24% |
| EBIT Margin | -11.24% |
| FCF Margin | -15.81% |
Dividends & Yields
InterCure does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.97% |
| Shareholder Yield | -0.97% |
| Earnings Yield | -16.28% |
| FCF Yield | -14.77% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 9, 2021. It was a reverse split with a ratio of 877:3902.
| Last Split Date | Apr 9, 2021 |
| Split Type | Reverse |
| Split Ratio | 877:3902 |
Scores
InterCure has an Altman Z-Score of 0.91 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.91 |
| Piotroski F-Score | 3 |